Monday 21 Jun, 2021 04:18 PM
Site map | Locate Us | Login
   Morgan Stanley Asia (Singapore) picks 0.58% stake in SBI Card    Bharat Dynamics slips after weak Q4 performance     Oriental Carbon & Chemicals Ltd leads losers in 'A' group    Palm Jewels Ltd leads losers in 'B' group    Volumes spurt at Timken India Ltd counter    Kiri Ind soars after SICC values Co's stake in DyStar at $481.6 mn    Capital Goods stocks edge lower    Information Technology stocks fall    Auto stocks slip    Power Grid Corporation of India Ltd stays slippery    Tata Motors Ltd drops for fifth straight session    State Bank of India drops for fifth straight session    CRISIL jumps 11% in three days    Route Mobile rises after parternship with Truecaller    Sun TV Network Ltd gains for fifth session 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Caplin Point Lab spurts after Q4 PAT rises 39% to Rs 68 cr
06-May-21   16:04 Hrs IST

On a consolidated basis, EBITDA surged 29.6% to Rs 95.15 crore in Q4 FY21 as against Rs 73.44 crore in Q4 FY20. EBITDA margin improved to 33% in Q4 FY21 from 31.3% in Q4 FY20.

The geographical breakup of sales were: Latin America at 87%; Africa at 5% and US at 8%. Given the continued focus on cash flow, receivables sustained at 95 days despite growth in sales. With focus on need to keep Inventory closer to customers, the current level of inventory is likely to continue at similar levels.

The cash and cash equivalent jumped 65.49% to Rs 470 crore as at 31 March 2021 as against Rs 284 crore at 31 March 2020. Inventory dropped 24.78% to Rs 179 crore as compared to Rs 238 crore in March 2020.

Caplin Point Laboratories is a fast growing pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.G Anand , anand@ssplwealth.com
Hit Count : 17027527
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016  |  MCX : INZ000081736
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 12815 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. Saravana Stocks Pvt. Ltd